Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H21N6.CH4O4S.CH3O4S |
| Molecular Weight | 532.591 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COS(O)(=O)=O.COS([O-])(=O)=O.CN1C(C)=C\C(=N\C2=CC3=C(N)C=C(C)[N+](C)=C3C=C2)N=C1N
InChI
InChIKey=WZIPHSLUGLMTRU-UHFFFAOYSA-N
InChI=1S/C17H20N6.2CH4O4S/c1-10-7-14(18)13-9-12(5-6-15(13)22(10)3)20-16-8-11(2)23(4)17(19)21-16;2*1-5-6(2,3)4/h5-9,18H,1-4H3,(H2,19,20,21);2*1H3,(H,2,3,4)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Studies of quinapyramine-resistance of Trypanosoma brucei evansi in China. | 2010-12 |
|
| In vitro activity and preliminary toxicity of various diamidine compounds against Trypanosoma evansi. | 2010-05-11 |
|
| Proteomics of Trypanosoma evansi infection in rodents. | 2010-03-22 |
|
| Immunobiology of African trypanosomes: need of alternative interventions. | 2010 |
|
| Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal. | 2009-09-29 |
|
| Development and application of an antibody-ELISA to follow up a Trypanosoma evansi outbreak in a dromedary camel herd in France. | 2009-06-10 |
|
| Health management of horses under high challenge from trypanosomes: a case study from Serengeti, Tanzania. | 2008-07-04 |
|
| The history of African trypanosomiasis. | 2008-02-12 |
|
| The effect of TAO expression on PCD-like phenomenon development and drug resistance in Trypanosoma brucei. | 2006-06 |
|
| Resistance to drug by different isolates Trypanosoma evansi in China. | 2004-05 |
|
| RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate. | 2003-10-22 |
|
| Antibody levels by indirect ELISA test in Trypanosoma evansi infected horses following treatment with quinapyramine sulphate. | 2003-01-20 |
|
| New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. | 1995-11-24 |
|
| Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. | 1992-09 |
|
| Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. | 1988-06 |
|
| Uridine 5'-diphosphate glucose analogues. Inhibitors of protein glycosylation that show antiviral activity. | 1985-01 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
221-894-0
Created by
admin on Mon Mar 31 21:22:29 GMT 2025 , Edited by admin on Mon Mar 31 21:22:29 GMT 2025
|
PRIMARY | |||
|
3270-78-8
Created by
admin on Mon Mar 31 21:22:29 GMT 2025 , Edited by admin on Mon Mar 31 21:22:29 GMT 2025
|
PRIMARY | |||
|
m9438
Created by
admin on Mon Mar 31 21:22:29 GMT 2025 , Edited by admin on Mon Mar 31 21:22:29 GMT 2025
|
PRIMARY | Merck Index | ||
|
197022
Created by
admin on Mon Mar 31 21:22:29 GMT 2025 , Edited by admin on Mon Mar 31 21:22:29 GMT 2025
|
PRIMARY | |||
|
G83ZS9Z22U
Created by
admin on Mon Mar 31 21:22:29 GMT 2025 , Edited by admin on Mon Mar 31 21:22:29 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD